Hemas Holdings (COL:HHL.N0000) Days Sales Outstanding : 82.82 (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Hemas Holdings Days Sales Outstanding?

Hemas Holdings's average Accounts Receivable for the three months ended in Dec. 2023 was රු28,337 Mil. Hemas Holdings's Revenue for the three months ended in Dec. 2023 was රු31,223 Mil. Hence, Hemas Holdings's Days Sales Outstanding for the three months ended in Dec. 2023 was 82.82.

The historical rank and industry rank for Hemas Holdings's Days Sales Outstanding or its related term are showing as below:

COL:HHL.N0000' s Days Sales Outstanding Range Over the Past 10 Years
Min: 49.66 Med: 68.59 Max: 78.3
Current: 75.37

During the past 13 years, Hemas Holdings's highest Days Sales Outstanding was 78.30. The lowest was 49.66. And the median was 68.59.

COL:HHL.N0000's Days Sales Outstanding is ranked worse than
61.65% of 498 companies
in the Conglomerates industry
Industry Median: 61.035 vs COL:HHL.N0000: 75.37

Hemas Holdings's Days Sales Outstanding declined from Dec. 2022 (90.43) to Dec. 2023 (82.82).

Hemas Holdings Days Sales Outstanding Historical Data

The historical data trend for Hemas Holdings's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hemas Holdings Days Sales Outstanding Chart

Hemas Holdings Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

70.08

78.30

62.95

55.31

49.66

Hemas Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															90.43	64.52	64.84	77.74	82.82

Competitive Comparison of Hemas Holdings's Days Sales Outstanding

For the Conglomerates subindustry, Hemas Holdings's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemas Holdings's Days Sales Outstanding Distribution in the Conglomerates Industry

For the Conglomerates industry and Industrials sector, Hemas Holdings's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Hemas Holdings's Days Sales Outstanding falls into.

Hemas Holdings Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Hemas Holdings's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (13759.137	+	17245.243)	/	2 )	/	113939.574	*	365
=	15502.19					/	113939.574	*	365
=	49.66

Hemas Holdings's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (26689.865	+	29983.847)	/	2 )	/	31222.706	*	365 / 4
=	28336.856					/	31222.706	*	365 / 4
=	82.82

Hemas Holdings (COL:HHL.N0000) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Hemas Holdings Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Hemas Holdings's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Hemas Holdings (COL:HHL.N0000) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Conglomerates » Hemas Holdings PLC (COL:HHL.N0000) » Definitions » Days Sales Outstanding

Traded in Other Exchanges

N/A

Address

No. 75, Braybrooke Place, Hemas House, Colombo, LKA, 02

Website

https://www.hemas.com

Hemas Holdings PLC holds investments in companies with diversified businesses in Sri Lanka. Its businesses include manufacturing, trading and distributing FMCG products, pharmaceutical products, healthcare products, provision of medical care, operating tourism business, hotel management, airlines, shipping business, IT solutions, among others. It has the following reportable segments: Consumer, Healthcare, Leisure, Travel & Aviation, Mobility, and Other segments. The healthcare segment which generates majority revenue distributes pharmaceuticals, surgical and diagnostics products, and owns and manages hospitals.

Hemas Holdings (COL:HHL.N0000) Headlines

No Headlines